61 related articles for article (PubMed ID: 26560086)
21. Perispinal Delivery of CNS Drugs.
Tobinick EL
CNS Drugs; 2016 Jun; 30(6):469-80. PubMed ID: 27120182
[TBL] [Abstract][Full Text] [Related]
22. Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.
Roerink ME; Groen RJ; Franssen G; Lemmers-van de Weem B; Boerman OC; van der Meer JW
Alzheimers Res Ther; 2015 Nov; 7(1):70. PubMed ID: 26560086
[TBL] [Abstract][Full Text] [Related]
23. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
Tobinick EL; Gross H
BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
[TBL] [Abstract][Full Text] [Related]
24. Perispinal etanercept: potential as an Alzheimer therapeutic.
Griffin WS
J Neuroinflammation; 2008 Jan; 5():3. PubMed ID: 18186919
[TBL] [Abstract][Full Text] [Related]
25. Perispinal etanercept for treatment of Alzheimer's disease.
Tobinick E
Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
[TBL] [Abstract][Full Text] [Related]
26. Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
Tobinick EL; Gross H
J Neuroinflammation; 2008 Jan; 5():2. PubMed ID: 18184433
[TBL] [Abstract][Full Text] [Related]
27. Treatment of post-anesthesia dementia with perispinal etanercept injection and hyperbaric oxygen therapy: a case report.
Best S; Pavel DG
J Med Case Rep; 2017 Apr; 11(1):105. PubMed ID: 28407792
[TBL] [Abstract][Full Text] [Related]
28. Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
Butchart J; Brook L; Hopkins V; Teeling J; Püntener U; Culliford D; Sharples R; Sharif S; McFarlane B; Raybould R; Thomas R; Passmore P; Perry VH; Holmes C
Neurology; 2015 May; 84(21):2161-8. PubMed ID: 25934853
[TBL] [Abstract][Full Text] [Related]
29. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research.
Cunningham C; Hennessy E
Alzheimers Res Ther; 2015; 7(1):33. PubMed ID: 25802557
[TBL] [Abstract][Full Text] [Related]
30. Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
Whitlock DR
CNS Drugs; 2014 Dec; 28(12):1205-6. PubMed ID: 25373628
[No Abstract] [Full Text] [Related]
31. Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review.
Bettcher BM; Kramer JH
Clin Pharmacol Ther; 2014 Oct; 96(4):464-9. PubMed ID: 25009982
[TBL] [Abstract][Full Text] [Related]
32. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
Ignatowski TA; Spengler RN; Dhandapani KM; Folkersma H; Butterworth RF; Tobinick E
CNS Drugs; 2014 Aug; 28(8):679-97. PubMed ID: 24861337
[TBL] [Abstract][Full Text] [Related]
33. Regulation of TNF-α with a focus on rheumatoid arthritis.
Moelants EA; Mortier A; Van Damme J; Proost P
Immunol Cell Biol; 2013 Jul; 91(6):393-401. PubMed ID: 23628802
[TBL] [Abstract][Full Text] [Related]
34. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.
Tobinick E
Curr Alzheimer Res; 2012 Jan; 9(1):99-109. PubMed ID: 22191562
[TBL] [Abstract][Full Text] [Related]
35. Proinflammatory cytokines, sickness behavior, and Alzheimer disease.
Holmes C; Cunningham C; Zotova E; Culliford D; Perry VH
Neurology; 2011 Jul; 77(3):212-8. PubMed ID: 21753171
[TBL] [Abstract][Full Text] [Related]
36. Perispinal etanercept: a new therapeutic paradigm in neurology.
Tobinick E
Expert Rev Neurother; 2010 Jun; 10(6):985-1002. PubMed ID: 20518613
[TBL] [Abstract][Full Text] [Related]
37. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.
Zotova E; Nicoll JA; Kalaria R; Holmes C; Boche D
Alzheimers Res Ther; 2010 Jan; 2(1):1. PubMed ID: 20122289
[TBL] [Abstract][Full Text] [Related]
38. Systemic inflammation and disease progression in Alzheimer disease.
Holmes C; Cunningham C; Zotova E; Woolford J; Dean C; Kerr S; Culliford D; Perry VH
Neurology; 2009 Sep; 73(10):768-74. PubMed ID: 19738171
[TBL] [Abstract][Full Text] [Related]
39. Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.
Tobinick EL; Chen K; Chen X
BMC Res Notes; 2009 Feb; 2():28. PubMed ID: 19284700
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
